Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heterogeneity in motoneuron disease.

Diether Lambrechts1, Wim Robberecht, Peter Carmeliet

  • 1The Center for Transgene Technology and Gene Therapy, K.U. Leuven, B-3000, Leuven, Belgium.

Trends in Neurosciences
|September 11, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinoma.

Nature medicine·2024
Same author

Distinct immunometabolic signatures in circulating immune cells define disease outcome in acute-on-chronic liver failure.

Hepatology (Baltimore, Md.)·2024
Same author

A likelihood ratio approach for utilizing case-control data in the clinical classification of rare sequence variants: application to <i>BRCA1</i> and <i>BRCA2</i>.

Human mutation·2024
Same author

Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions.

American journal of human genetics·2024
Same author

PI3K/mTOR inhibition induces tumour microenvironment remodelling and sensitises pS6<sup>high</sup> uterine leiomyosarcoma to PD-1 blockade.

Clinical and translational medicine·2024
Same author

Single-cell Atlas of Penile Cancer Reveals TP53 Mutations as a Driver of an Aggressive Phenotype, Irrespective of Human Papillomavirus Status, and Provides Clues for Treatment Personalization.

European urology·2024

Genetic mutations cause motoneuron degeneration, leading to varied clinical syndromes. Understanding common mechanisms is key for effective motoneuron disease therapies, acknowledging treatment heterogeneity.

Area of Science:

  • Neuroscience
  • Genetics
  • Neurology

Background:

  • Mutations in specific genes are identified as primary causes of motoneuron degeneration.
  • These genetic mutations have been linked to clinically distinct motoneuron syndromes.
  • This challenges traditional diagnostic classifications based on clinical judgment.

Purpose of the Study:

  • To investigate the mechanisms underlying motoneuron degeneration.
  • To explore the heterogeneity in motoneuron disease phenotypes.
  • To identify common principles for effective therapeutic target identification.

Main Methods:

  • Gene mutation analysis in motoneuron disease patients.
  • Clinical phenotyping of affected individuals.
  • Molecular mechanism investigation.

Related Experiment Videos

Main Results:

  • Identified mutations in several genes causing motoneuron degeneration.
  • Demonstrated that the same gene mutations can result in different clinical presentations.
  • Revealed that overlapping motoneuron phenotypes can arise from diverse molecular pathways.

Conclusions:

  • Motoneuron disease exhibits significant heterogeneity at both clinical and molecular levels.
  • Identifying common underlying mechanisms is crucial for developing targeted therapies.
  • A single therapeutic approach may not suffice; pre-clinical testing requires diverse models.